Human umbilical cord blood mesenchymal stem cell therapy (Xijing Hospital)

N/A

Report date: 2023/01/12 15:47:48

Base Information

Drug NameHuman umbilical cord blood mesenchymal stem cell therapy (Xijing Hospital)
Drug Alias Name人脐带血间充质干细胞疗法-西京医院/海军军医大学附属长海医院/重庆西南医院UC-MSCs (Xijing Hospital)
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusClinical
Highest Status in ChinaClinical
Originator CompaniesChanghai Hospital of Navy Medical UniversityThe First Affiliated Hospital of Air Force Medical UniversityThe Southwest Hospital of AMU
China Registration ClassN/A

Develop Information

Active CompaniesThe First Affiliated Hospital of Air Force Medical UniversityChanghai Hospital of Navy Medical UniversityThe Southwest Hospital of AMU
Inactive CompaniesN/A
Active IndicationsArthritis, Rheumatoid
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A